Mackenzie Financial Corp Seelos Therapeutics, Inc. Transaction History

Mackenzie Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.59 - $2.38 $141,982 - $212,526	-89,297 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$1.69 - $2.89 $3,214 - $5,496	1,902 Added 2.18%	89,297 $215,000
Q2 2021 Aug 11, 2021	BUY	$2.64 - $6.32 $230,722 - $552,336	87,395 New	87,395 $231,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.